Kozak & Associates
LFVN icon

Kozak & Associates’s LifeVantage LFVN Stock Holding History

Kozak & Associates’s Portfolio LFVN Stock Details LFVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$147 Hold
25
– – ﹤0.01% 383
2026
Q2 		$156 Hold
25
– – ﹤0.01% 414
2026
Q1 		$104 Hold
25
– – ﹤0.01% 425
2025
Q4 		$162 Hold
25
– – ﹤0.01% 410
2025
Q3 		$157 Hold
25
– – ﹤0.01% 431
2025
Q2 		$327 Hold
25
– – ﹤0.01% 390
2025
Q1 		$356 Hold
25
– – ﹤0.01% 403
2024
Q4 		$445 Hold
25
– – ﹤0.01% 391
2024
Q3 		$296 Hold
25
– – ﹤0.01% 365
2024
Q2 		$150 Hold
25
– – ﹤0.01% 368
2024
Q1 		$180 Buy
+25
New +$158 ﹤0.01% 372

Other funds holding LFVN

CM
Capital Management Glen Allen, Virginia $668M AUM 8.93% 1-Year Est. Return
Indivisible Partners
Indivisible Partners Clearwater, Florida $2.18B AUM 33.61% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return
Simplicity Wealth
Simplicity Wealth Summit, New Jersey $3.43B AUM 16.22% 1-Year Est. Return
New England Professional Planning Group
New England Professional Planning Group Westerly, Rhode Island $263M AUM 13.79% 1-Year Est. Return
TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return
Blue Trust Inc
Blue Trust Inc Alpharetta, Georgia $9.5B AUM 13.02% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Physician Wealth Advisors
Physician Wealth Advisors Midvale, Utah $869M AUM 17.6% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Kozak & Associates's LFVN Position: Q3 2026 in Review

Kozak & Associates held its LifeVantage (LFVN) position steady in Q3 2026 at 25 shares worth $147. The position accounts for ﹤0.01% of the portfolio, ranked #383.

Kozak & Associates first reported a position in LFVN in Q1 2024 and has held it in 11 quarters since. The position peaked at $445 in Q4 2024. 17 funds tracked by Wall St. Rank hold LFVN as of Q3 2026.

  • Kozak & Associates held 25 shares of LifeVantage worth $147 as of Q3 2026.
  • Kozak & Associates left its LifeVantage share count unchanged in Q3 2026.
  • LifeVantage made up ﹤0.01% of Kozak & Associates's portfolio in Q3 2026, its #383 holding.
  • Kozak & Associates first reported a position in LifeVantage in Q1 2024 and has held it in 11 quarters since.
  • Kozak & Associates's LifeVantage position peaked at $445 in Q4 2024.
  • 17 funds tracked by Wall St. Rank held LifeVantage as of Q3 2026.

Based on Kozak & Associates's 13F filing for Q3 2026, filed 29 Oct 2026.